Providing Regulatory Submissions in Electronic Format; General Considerations
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 28, 1999
May 15, 2020
09112e28-964d-4af6-8d59-7a42a1aab244
Related Documents
Monoclonal Antibodies Used as Reagents in Drug Manufacturing
Guidance DocumentMarch 1, 2001Center for Drug Evaluation and Research
E9 Statistical Principles for Clinical Trials
Guidance DocumentSeptember 16, 1998Center for Drug Evaluation and Research
Providing Regulatory Submissions in Electronic Format — Content of Labeling
Guidance DocumentApril 21, 2005Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.